The authors reply

New England Journal of Medicine

Volumn 362, Issue 20, 2010, Pages 1941-1942

  Barnes, Aileen M ^a   Raggio, Cathleen L ^b   Marini, Joan C ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b HOSPITAL FOR SPECIAL SURGERY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN TYPE 1; CRTAP PROTEIN; CYPB PROTEIN; GUANIDINE; METHIONINE; P3H1 PROTEIN; PROTEIN; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; CELL LYSATE; GENE MUTATION; GENETIC COUNSELING; GENOMICS; LETTER; MISSENSE MUTATION; OSTEOGENESIS IMPERFECTA; PHENOTYPE; PLASMID; PRIORITY JOURNAL; PROTEIN DEFICIENCY; WESTERN BLOTTING;

EID: 77952632630     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: None     Document Type: Letter

References (6)

1. Tryon RC, White SD, Bannasch DL. Homozygosity mapping approach identifies a missense mutation in equine cyclophilin B (PPIB) associated with HERDA in the American Quarter Horse. Genomics 2007;90:93-102.
2. Rycyzyn MA, Reilly SC, O'Malley K, Clevenger CV. Role of cyclophilin B in prolactin signal transduction and nuclear retro-translocation. Mol Endocrinol 2000;14:1175-1186 (Pubitemid 32260479)
3. van Dijk FS, Nesbitt IM, Zwikstra EH, et al. PPIB mutations cause severe osteogenesis imperfecta. Am J Hum Genet 2009; 85:521-527
4. Schwarze U, Pyott S, Russell D, Sussman M, Harris C, Byers PH. Mutations in PPIB, which encodes a prolyl cis-trans isomerase (cyclophilin B), in recessive forms of osteogenesis imperfecta (OI). In: Program and abstracts of the 59th Annual Meeting of the American Society of Human Genetics, Honolulu, October 20-24, 2009:73. abstract. (Accessed April 29, 2010, at http://www.ashg.org/2009meeting/pdf/platforms-4up.pdf.)
5. Van Dijk FS, Pals G, Van Rijn RR, Nikkels PG, Cobben JM. Classification of osteogenesis imperfecta revisited. Eur J Med Genet 2010;53:1-5.
6. Sillence DO, Senn A, Danks DM. Genetic heterogeneity in osteogenesis imperfecta. J Med Genet 1979;16:101-116